NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹17.60
-0.37%
NAV as on 05 Oct 24, 12:00 AM
very high risk
index funds
equity
NAV as on 05 Oct 24, 12:00 AM
very high risk
index funds
equity
50.34%p.a.
Last 1Y
0.00%p.a.
Last 3Y
0.00%p.a.
Last 5Y
38.13%p.a.
Since Inception
About ICICI Prudential Nifty Pharma Index Fund Growth for NRIs
NRIs can achieve long-term capital appreciation by investing in the ICICI Prudential Nifty Pharma Index Fund Growth scheme from ICICI Prudential Asset Management Company Limited. It is a Index Funds mutual fund scheme that predominantly invests in Index Funds stocks of companies. Launched on Dec 2022, ICICI Prudential Nifty Pharma Index Fund Growth is Index Funds fund of its category with 72.14 Cr fund under management as on Oct 2024. The expense ratio of this fund is less than that of most other Fund category Index Funds funds.
- ICICI Prudential Nifty Pharma Index Fund Growth delivered 50.3% annual returns during the last year. It has delivered 38.1% average annual returns since the fund was launched.
- ICICI Prudential Nifty Pharma Index Fund Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
- The scheme has predominantly invested in equity
Fund Objective
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd
24.91%
Cipla Ltd
11.00%
Dr Reddy's Laboratories Ltd
10.84%
Divi's Laboratories Ltd
8.22%
Lupin Ltd
6.86%
Aurobindo Pharma Ltd
5.59%
Torrent Pharmaceuticals Ltd
4.03%
Alkem Laboratories Ltd
3.92%
Zydus Lifesciences Ltd
3.59%
Glenmark Pharmaceuticals Ltd
3.28%
Fund Managers
- Nishit Patel (Dec 2022 - Present)
- Priya Sridhar (Feb 2024 - Present)
Key Information
View Scheme Document
ICICI Prudential Nifty Pharma Index Fund Growth SIP Calculator
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
NRI Mutual Fund Tax on ICICI Prudential Nifty Pharma Index Fund Growth
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
| Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
|---|---|---|
| Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
| Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
How can NRIs invest in ICICI Prudential Nifty Pharma Index Fund Growth?
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
- Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
- PAN Number
- Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
- Passport – front and back
- Passport size photograph
- signature
If all details are correct, your KYC will be approved within 7 to 8 business days.
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in ICICI Prudential Nifty Pharma Index Fund Growth
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
- City and country of birth
- NRE/NRO bank account statement/ canceled cheque for the latest 3 months
- Nominee details
Similar Funds
Funds
3Y Return
UTI Nifty 50 Index Fund Plan Growth
very high risk | equity
13.2%
HDFC Index Nifty 50
very high risk | equity
13.1%
ICICI Prudential Nifty 50 Index Plan Growth
very high risk | equity
13.1%
Frequently Asked Questions
Copyright | 2021 @ SBNRI | All Rights Reserved